Median (±SD) Survival at 120 Days after Radiotherapy, Radionuclide Therapy with 131I-IPA, and Combined Radiotherapy and 131I-IPA Treatment
| Treatment group | Control | Radiotherapy | 131I-IPA | Radiotherapy/131I-IPA |
|---|---|---|---|---|
| Fischer–F98 | 0 | 0 | 8% ± 5% | 20% ± 6% |
| RNU–Tx3868 | 0 | 22% ± 4% | 55% ± 8% | 65% ± 10% |
| RNU–A1207 | 0 | 20% ± 5% | 45% ± 5% | 52% ± 5% |
n = 12 for each glioma model in each treatment group.